Liver Neoplasms, Experimental
"Liver Neoplasms, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Experimentally induced tumors of the LIVER.
| Descriptor ID |
D008114
|
| MeSH Number(s) |
C04.588.274.623.460 C04.619.540 C06.301.623.460 C06.552.697.580 E05.598.500.496.750
|
| Concept/Terms |
Liver Neoplasms, Experimental- Liver Neoplasms, Experimental
- Experimental Liver Neoplasm
- Liver Neoplasm, Experimental
- Neoplasms, Experimental Liver
- Experimental Liver Neoplasms
Experimental Hepatoma- Experimental Hepatoma
- Hepatoma, Experimental
- Hepatomas, Experimental
- Experimental Hepatomas
|
Below are MeSH descriptors whose meaning is more general than "Liver Neoplasms, Experimental".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Site [C04.588]
- Digestive System Neoplasms [C04.588.274]
- Liver Neoplasms [C04.588.274.623]
- Liver Neoplasms, Experimental [C04.588.274.623.460]
- Neoplasms, Experimental [C04.619]
- Liver Neoplasms, Experimental [C04.619.540]
- Digestive System Diseases [C06]
- Digestive System Neoplasms [C06.301]
- Liver Neoplasms [C06.301.623]
- Liver Neoplasms, Experimental [C06.301.623.460]
- Liver Diseases [C06.552]
- Liver Neoplasms [C06.552.697]
- Liver Neoplasms, Experimental [C06.552.697.580]
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Investigative Techniques [E05]
- Models, Animal [E05.598]
- Disease Models, Animal [E05.598.500]
- Neoplasms, Experimental [E05.598.500.496]
- Liver Neoplasms, Experimental [E05.598.500.496.750]
Below are MeSH descriptors whose meaning is more specific than "Liver Neoplasms, Experimental".
This graph shows the total number of publications written about "Liver Neoplasms, Experimental" by people in this website by year, and whether "Liver Neoplasms, Experimental" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1996 | 2 | 0 | 2 |
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 1 | 1 | 2 |
| 2005 | 1 | 1 | 2 |
| 2007 | 2 | 1 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 2 | 0 | 2 |
| 2019 | 0 | 1 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver Neoplasms, Experimental" by people in Profiles.
-
Quantitative Dual-Energy CT Image Guidance for Thermochemical Ablation: In?Vivo Results in the Rabbit VX2 Model. J Vasc Interv Radiol. 2023 05; 34(5):782-789.
-
Loss of Hepatic Transcription Factor EB Attenuates Alcohol-Associated Liver Carcinogenesis. Am J Pathol. 2022 01; 192(1):87-103.
-
Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. J Clin Invest. 2021 06 01; 131(11).
-
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination. Nat Med. 2021 01; 27(1):152-164.
-
Three-Dimensional Augmented Reality Visualization Informs Locoregional Therapy in a Translational Model of Hepatocellular Carcinoma. J Vasc Interv Radiol. 2020 Oct; 31(10):1612-1618.e1.
-
Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma. Cancer Prev Res (Phila). 2020 06; 13(6):497-508.
-
Establishment of hepatocellular carcinoma patient-derived xenografts from image-guided percutaneous biopsies. Sci Rep. 2019 07 22; 9(1):10546.
-
Improved, Shorter-Latency Carcinogen-Induced Hepatocellular Carcinoma Model in Pigs. Oncology. 2018; 95(6):360-369.
-
Manganese-Based Contrast Agents for Magnetic Resonance Imaging of Liver Tumors: Structure-Activity Relationships and Lead Candidate Evaluation. J Med Chem. 2018 10 11; 61(19):8811-8824.
-
Depletion of S100A4+ stromal cells does not prevent HCC development but reduces the stem cell-like phenotype of the tumors. Exp Mol Med. 2018 01 05; 50(1):e422.